America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide, the Pharmaceutical Research and Manufacturers of America announced Tuesday.
The United States Hispanic Chamber of Commerce welcomed Boehringer Ingelheim Pharmaceuticals to its family of corporate members as a strategic partner.
Novo Nordisk has launched a new insulin pen designed for children with diabetes.
A physician in Mississippi is warning that one-third of the state's population could have diabetes in less than two decades, according to published reports.
The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said.
Diabetes organizations in several cities are getting a boost in funding from a Danish drug maker that specializes in developing treatments for the disease.
Federal regulators are lifting some restrictions on a diabetes drug that were placed two years ago after studies linked the drug to increased cardiovascular risk.
A former executive from Cisco has been appointed as CEO of the International Diabetes Federation.
Many physicians in Asia say more information on managing Type 2 diabetes is needed, according to a new poll.
Half of people with diabetes feel overwhelmed in managing their disease and diet, according to a new survey conducted by Meijer.